PL2889298T3 - Pochodna pirazolopirymidyny podstawiona w pozycji 4 i jej zastosowanie do wytwarzania leku - Google Patents
Pochodna pirazolopirymidyny podstawiona w pozycji 4 i jej zastosowanie do wytwarzania lekuInfo
- Publication number
- PL2889298T3 PL2889298T3 PL13822476T PL13822476T PL2889298T3 PL 2889298 T3 PL2889298 T3 PL 2889298T3 PL 13822476 T PL13822476 T PL 13822476T PL 13822476 T PL13822476 T PL 13822476T PL 2889298 T3 PL2889298 T3 PL 2889298T3
- Authority
- PL
- Poland
- Prior art keywords
- drug preparation
- position substituted
- pyrazolopyrimidine derivative
- substituted pyrazolopyrimidine
- derivative
- Prior art date
Links
- OGEBRHQLRGFBNV-RZDIXWSQSA-N chembl2036808 Chemical class C12=NC(NCCCC)=NC=C2C(C=2C=CC(F)=CC=2)=NN1C[C@H]1CC[C@H](N)CC1 OGEBRHQLRGFBNV-RZDIXWSQSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cosmetics (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210264034.2A CN103570723B (zh) | 2012-07-27 | 2012-07-27 | 吡唑并嘧啶衍生物及其制备方法和在药物制备中的用途 |
| EP13822476.1A EP2889298B1 (en) | 2012-07-27 | 2013-03-05 | 4-position substituted pyrazolopyrimidine derivative, and use thereof in drug preparation |
| PCT/CN2013/072185 WO2014015673A1 (zh) | 2012-07-27 | 2013-03-05 | 4位有取代的吡唑并嘧啶衍生物及其在药物制备中的用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2889298T3 true PL2889298T3 (pl) | 2018-11-30 |
Family
ID=49996553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13822476T PL2889298T3 (pl) | 2012-07-27 | 2013-03-05 | Pochodna pirazolopirymidyny podstawiona w pozycji 4 i jej zastosowanie do wytwarzania leku |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9828375B2 (pl) |
| EP (1) | EP2889298B1 (pl) |
| JP (1) | JP6063566B2 (pl) |
| KR (1) | KR101763273B1 (pl) |
| CN (1) | CN103570723B (pl) |
| CA (1) | CA2880196C (pl) |
| CY (1) | CY1120460T1 (pl) |
| DK (1) | DK2889298T3 (pl) |
| ES (1) | ES2682343T3 (pl) |
| HR (1) | HRP20181172T1 (pl) |
| HU (1) | HUE038634T2 (pl) |
| LT (1) | LT2889298T (pl) |
| PL (1) | PL2889298T3 (pl) |
| PT (1) | PT2889298T (pl) |
| RS (1) | RS57509B1 (pl) |
| SI (1) | SI2889298T1 (pl) |
| SM (1) | SMT201800394T1 (pl) |
| WO (1) | WO2014015673A1 (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9522929B2 (en) | 2014-05-05 | 2016-12-20 | Conagen Inc. | Non-caloric sweetener |
| KR20170007311A (ko) * | 2014-05-28 | 2017-01-18 | 노파르티스 아게 | 신규 피라졸로 피리미딘 유도체 및 malt1 억제제로서의 그의 용도 |
| WO2017184775A1 (en) * | 2016-04-19 | 2017-10-26 | The Regents Of The University Of California | Erbb inhibitors and uses thereof |
| CN107459521B (zh) * | 2016-06-03 | 2021-04-16 | 合肥中科普瑞昇生物医药科技有限公司 | Flt3激酶的新型抑制剂及其用途 |
| CN108341813B (zh) * | 2017-01-24 | 2020-11-17 | 四川大学 | 取代的1-(异恶唑-3-基)-3-(3-氟-4-苯基)脲衍生物及其制备方法和用途 |
| CN109180677A (zh) * | 2017-06-30 | 2019-01-11 | 厦门大学 | 取代芳基醚类化合物、其制备方法、药用组合物及其应用 |
| CN110833558B (zh) * | 2018-08-15 | 2021-07-30 | 广西梧州制药（集团）股份有限公司 | 吡唑并嘧啶衍生物在治疗糖尿病肾病的用途 |
| CN110833554B (zh) * | 2018-08-15 | 2022-03-08 | 广西梧州制药（集团）股份有限公司 | 吡唑并嘧啶衍生物在治疗自身免疫性甲状腺疾病的用途 |
| CN110833556A (zh) * | 2018-08-15 | 2020-02-25 | 广西梧州制药（集团）股份有限公司 | 吡唑并嘧啶衍生物在治疗肝纤维化的用途 |
| CN111249283A (zh) * | 2018-11-30 | 2020-06-09 | 四川大学 | 具有抗癌作用的嘧啶衍生物 |
| CN112794855B (zh) * | 2019-11-13 | 2023-07-28 | 中国药科大学 | N-芳基嘧啶-4-胺类衍生物的制备方法与应用 |
| CN112225748B (zh) * | 2020-10-20 | 2021-11-30 | 四川大学华西医院 | 一种具有flt3激酶抑制活性的小分子化合物及其应用 |
| CN112843066B (zh) * | 2021-02-04 | 2023-04-28 | 广西中恒创新医药研究有限公司 | 具良好溶解度的含吡唑并嘧啶衍生物的组合物及其应用 |
| TW202413367A (zh) * | 2022-08-19 | 2024-04-01 | 財團法人國家衛生研究院 | Ｔａｍ受體抑制劑 |
| CN115557953B (zh) * | 2022-10-22 | 2024-07-19 | 浙江工业大学 | N-苯基苯甲酰氨基吡唑并嘧啶类化合物及其制备和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9906566D0 (en) * | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
| TW200400034A (en) * | 2002-05-20 | 2004-01-01 | Bristol Myers Squibb Co | Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| EP1638966B1 (en) * | 2003-05-28 | 2008-03-19 | Universita Degli Studi Di Siena | 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO ¬3,4-d PYRIMIDINE AND USES THEREOF |
| GB0326168D0 (en) * | 2003-11-10 | 2003-12-17 | Arrow Therapeutics Ltd | Chemical compounds |
| JP5368701B2 (ja) * | 2004-07-02 | 2013-12-18 | エクセリクシス、インコーポレイテッド | ｃ−Ｍｅｔモジュレーター及び使用方法 |
| DE102005037499A1 (de) * | 2005-08-09 | 2007-02-15 | Merck Patent Gmbh | Pyrazolderivate |
| PL1940844T3 (pl) * | 2005-10-28 | 2010-03-31 | Irm Llc | Związki i kompozycje jako inhibitory kinazy białkowej |
| GB0524436D0 (en) * | 2005-11-30 | 2006-01-11 | Novartis Ag | Organic compounds |
| JP2011063516A (ja) * | 2009-09-15 | 2011-03-31 | Daiichi Sankyo Co Ltd | アミド誘導体 |
| US9180127B2 (en) * | 2009-12-29 | 2015-11-10 | Dana-Farber Cancer Institute, Inc. | Type II Raf kinase inhibitors |
-
2012
- 2012-07-27 CN CN201210264034.2A patent/CN103570723B/zh active Active
-
2013
- 2013-03-05 HR HRP20181172TT patent/HRP20181172T1/hr unknown
- 2013-03-05 US US14/417,588 patent/US9828375B2/en active Active
- 2013-03-05 CA CA2880196A patent/CA2880196C/en active Active
- 2013-03-05 HU HUE13822476A patent/HUE038634T2/hu unknown
- 2013-03-05 KR KR1020157005218A patent/KR101763273B1/ko active Active
- 2013-03-05 JP JP2015523378A patent/JP6063566B2/ja active Active
- 2013-03-05 SI SI201331113T patent/SI2889298T1/sl unknown
- 2013-03-05 PL PL13822476T patent/PL2889298T3/pl unknown
- 2013-03-05 WO PCT/CN2013/072185 patent/WO2014015673A1/zh not_active Ceased
- 2013-03-05 PT PT138224761T patent/PT2889298T/pt unknown
- 2013-03-05 DK DK13822476.1T patent/DK2889298T3/en active
- 2013-03-05 RS RS20180869A patent/RS57509B1/sr unknown
- 2013-03-05 EP EP13822476.1A patent/EP2889298B1/en active Active
- 2013-03-05 ES ES13822476.1T patent/ES2682343T3/es active Active
- 2013-03-05 SM SM20180394T patent/SMT201800394T1/it unknown
- 2013-03-05 LT LTEP13822476.1T patent/LT2889298T/lt unknown
-
2018
- 2018-07-25 CY CY20181100774T patent/CY1120460T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2889298T1 (sl) | 2018-11-30 |
| EP2889298B1 (en) | 2018-05-02 |
| CA2880196A1 (en) | 2014-01-30 |
| DK2889298T3 (en) | 2018-08-06 |
| CN103570723B (zh) | 2016-07-13 |
| HRP20181172T1 (hr) | 2018-09-21 |
| ES2682343T3 (es) | 2018-09-20 |
| JP6063566B2 (ja) | 2017-01-18 |
| WO2014015673A1 (zh) | 2014-01-30 |
| US9828375B2 (en) | 2017-11-28 |
| PT2889298T (pt) | 2018-08-06 |
| EP2889298A4 (en) | 2016-06-01 |
| KR20150036783A (ko) | 2015-04-07 |
| US20150315191A1 (en) | 2015-11-05 |
| JP2015522627A (ja) | 2015-08-06 |
| CA2880196C (en) | 2019-09-03 |
| LT2889298T (lt) | 2018-09-25 |
| CY1120460T1 (el) | 2019-07-10 |
| AU2013296011B2 (en) | 2016-09-29 |
| SMT201800394T1 (it) | 2018-09-13 |
| HUE038634T2 (hu) | 2018-11-28 |
| EP2889298A1 (en) | 2015-07-01 |
| CN103570723A (zh) | 2014-02-12 |
| RS57509B1 (sr) | 2018-10-31 |
| AU2013296011A1 (en) | 2015-02-19 |
| KR101763273B1 (ko) | 2017-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE038634T2 (hu) | A 4-helyzetben helyettesített pirazol-pirimidin-származékok, és alkalmazásuk a gyógyszer gyártásban | |
| HUS1800035I1 (hu) | Policiklusos karbamoilpiridon vegyületek és gyógyszerészeti alkalmazásuk | |
| IL231386A0 (en) | Pyrazoloquinolinone derivatives, their preparation and medical use | |
| SI2894151T1 (sl) | Imidazolinski derivati, postopki za njihovo pripravo in njihove uporabe v medicini | |
| IL234628A0 (en) | Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs | |
| IL231382A (en) | History of benzonitrile, their preparation and medications containing them | |
| EP2828258A4 (en) | NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE | |
| EP2995604A4 (en) | Phenol derivative and preparation method and use in medicine thereof | |
| IL229963A (en) | Converted quinolines and their use as drugs | |
| EP2803664A4 (en) | POLYCYCLIC DERIVATIVES, PROCESS FOR PREPARING THEM AND MEDICAL USES THEREOF | |
| IL233238A (en) | Sulphonylaminopyrrolidinone derivatives, their preparation and therapeutic use | |
| EP2805954A4 (en) | 7-SUBSTITUTED HANFANGICHIN B DERIVATIVE AND MANUFACTURING METHOD AND USE THEREOF | |
| GB201218084D0 (en) | Novel compounds and methods for use in medicine | |
| SI2882715T1 (sl) | Derivati pirazola in njihova uporaba kot antagonisti LPAR5 | |
| PT2870145T (pt) | Derivados de indeno, sua preparação e utilização como medicamentos | |
| ZA201501597B (en) | Macrolide derivatives,preparation thereof and therapeutic use thereof | |
| EP2940008A4 (en) | Novel benzazepine derivative and pharmaceutical use thereof | |
| PT2895176T (pt) | Intermediário de rivaroxabano e a sua preparação | |
| GB201210410D0 (en) | Improvements in antimicrobial drugs |